Abstract:Brain tumor segmentation is an important technique in computer-assisted diagnosis. To improve brain tumor diagnosis, it is necessary to use biochemical information provided by magnetic resonance spectroscopy (MRS). Some of the challenges involved are determining how to combine multimodal signals such as proton MRS and morphological or structural images, then knowing how to use the combined information to make a decision. In this paper, we propose using a data fusion method to perform an automatic segmentation of the brain tumor areas. To diagnose brain tissue abnormalities such as tumors, we need to use multispectral magnetic resonance images (MRIs), e.g. T1-weighted, T2-weighted, gadolinium, or FLAIR to determine some properties of the tumor, including size, position, sort, and relationship with other tissues. However, the tumor type and grade are usually diagnosed from histopathological examination of a surgical specimen. Proton (1H) magnetic resonance spectroscopy (MRS) is a non invasive MR technique that provides biochemical information about metabolites. The major biochemical characteristics can provide useful information about brain tumor type and grade (Howe et al., 2003a; 2003b). In many studies, the use of in vivo 1H-MRS has been described for determining tumor type and grade (Howe et al., 2003a; Howe et al., 2003b; Preul et al., 1996; Majos et al., 2009). Since analysis of in vivo MRS measurements are dependent on acquisition techniques that could compromise the spatial resolution and accuracy of resulting metabolite values (Maudsley et al., 2009), metabolic changes associated with disease are frequently small and diffuse. Furthermore, using the chemical-shift imaging (CSI) technique, metabolite images, known as MR spectroscopic imaging (MRSI) images, can be created using multivoxel MRS information, but it is not as visually interpretable as in a structural MRI (Maudsley et al., 2009). So, for tumor tissue classification, it is important that MRSI be combined with MRI to make a more accurate estimation of variations in metabolites, support hypotheses of metabolite variation causes, and to yield sufficient information about the tissue. For over a decade, scientists have been developing automated brain-tumor classification methods using MRS (Garcia-Gomez et al., 2009), but a more clear definition of brain tumor type and grade may be obtained by combining MRS or MRSI and MRI (Garcia-Gomez et al., 2009). A technique used to differentiate glioblastoma from metastatic lesions using MRI and

Integrating HRMAS-NMR Data and Machine Learning-Assisted Profiling of Metabolite Fluxes to Classify Low- and High-Grade Gliomas

Dysregulated Alanine as a Potential Predictive Marker of Glioma—An Insight from Untargeted HRMAS-NMR and Machine Learning Data

Grade classification of neuroepithelial tumors using high-resolution magic-angle spinning proton nuclear magnetic resonance spectroscopy and pattern recognition

Metabolic Variations between Low-Grade and High-Grade Gliomas-Profiling by 1H NMR Spectroscopy

Targeted metabolomics analyses for brain tumor margin assessment during surgery

Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes

Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning

Malignancy-associated metabolic profiling of human glioma cell lines using 1 H NMR spectroscopy

Metabolomic Profiling and Machine Learning Models for Tumor Classification in Patients with Recurrent IDH-Wild-Type Glioblastoma: A Prospective Study

Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups

Targeted Metabolic Profiling in Determining the Metabolic Heterogeneity in Human Biopsies of Different Grades of Glioma

Metabolomic characterization of human glioblastomas and patient plasma: a pilot study

Accurate and rapid molecular subgrouping of high-grade glioma via deep learning-assisted label-free fiber-optic Raman spectroscopy

Metabolic Detection of Malignant Brain Gliomas Through Plasma Lipidomic Analysis and Support Vector Machine-Based Machine Learning

Glial Tumors: Quantification and Segmentation from MRI and MRS

Noninvasive Evaluation of Cerebral Glioma Grade by Using Multivoxel 3D Proton MR Spectroscopy.

Machine-learning-based Classification of Lower-grade gliomas and High-grade gliomas using Radiomic Features in Multi-parametric MRI

Assessing Metabolic Markers in Glioblastoma Using Machine Learning: A Systematic Review

Tmet-23. Mass Spectrometry-Based Metabolic Profiling And Imaging Of Astrocyte And Glioblastoma Invasive Margin Cells

In Vitro Brain Tumors: Initial Study Using High Resolution Magic Angle Spinning 1H MR Spectroscopy

Metabolomic Differentiation of Tumor Core vs. Edge in Glioma Via Machine Learning